TC BIOPHARM HOLDINGS PLC's ticker is and the CUSIP is 87807D111. A total of 8 filers reported holding TC BIOPHARM HOLDINGS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,176 | -48.8% | 235,294 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $10,118 | -57.0% | 235,294 | 0.0% | 0.00% | -50.0% |
Q1 2023 | $23,506 | +11.7% | 235,294 | 0.0% | 0.00% | +100.0% |
Q4 2022 | $21,047 | -27.4% | 235,294 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $29,000 | -48.2% | 235,294 | 0.0% | 0.00% | -33.3% |
Q2 2022 | $56,000 | -52.1% | 235,294 | 0.0% | 0.00% | -40.0% |
Q1 2022 | $117,000 | – | 235,294 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Empery Asset Management, LP | 2,823,528 | $1,384,000 | 6.50% |
Altium Capital Management LP | 941,176 | $461,000 | 0.15% |
ARMISTICE CAPITAL, LLC | 1,882,352 | $922,000 | 0.02% |
Kepos Capital LP | 470,588 | $231,000 | 0.02% |
Nantahala Capital Management | 235,294 | $117,000 | 0.01% |
Virtu Financial LLC | 15,775 | $8,000 | 0.00% |
Warberg Asset Management LLC | 176,534 | $88,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |